domingo, 14 de octubre de 2012

CDC - HAI - CDC Responds to Multistate Fungal Meningitis Outbreak


Current Situation

October 14, 2012 10:30 AM EDT

CDC Responds to Multistate Fungal Meningitis Outbreak

The Centers for Disease Control and Prevention (CDC) with state and local health departments and the Food and Drug Administration (FDA)External Web Site Icon are investigating a multistate meningitis outbreak of fungal infections among patients who have received a steroid injection of a potentially contaminated product into the spinal area. Several patients suffered strokes that are believed to have resulted from their infection. The investigation also includes fungal infections associated with injections in a peripheral joint space, such as a knee, shoulder or ankle. CDC and public health officials are referring any patients who have symptoms that suggest possible meningitis or a possible peripheral joint infection to their physicians who can evaluate them further. Those patients injected in peripheral joints only are not believed to be at risk for fungal meningitis but could be at risk for joint infection.
  • CDC's guidance to patients has not changed as a result of the expanded voluntary recall of all New England Compounding Center (NECC) productsExternal Web Site Icon, announced October 6. Patients who feel ill and are concerned about whether they received a medication from one of the NECC products recalled on September 26 should contact their physician.
  • The type of meningitis that has been found in the investigation is caused by fungi (Exserohilum and Aspergillus) that are common in the environment but rarely cause meningitis. This form of fungal meningitis is not contagious.
  • Clinicians should contact patients who have received medicines associated with three lots of preservative-free methylprednisolone acetate (80mg/ml) from the NECC that were recalled on September 26, 2012. The potentially contaminated injections were given starting May 21, 2012. See updated Clinician Guidance for more information, including new case definitions.
  • Patients and clinicians need to remain vigilant for onset of symptoms because fungal infections can be slow to develop. In this outbreak symptoms typically have appeared 1 to 4 weeks following injection, but it’s important to know that longer and shorter periods of time between injection and onset of symptoms have been reported. Therefore, patients and physicians need to closely watch for symptoms for at least several months following the injection. See updated Patient Guidance for more information, and contact your physician if you are concerned you may have become ill from your injection.

No hay comentarios:

Publicar un comentario